Research
We are driving the next generation of discoveries to address critical cancer challenges and accelerate the translation of scientific evidence into patient benefit.
Education
Fostering an outstanding cancer care workforce to help maintain and enhance world-leading patient outcomes through online learning, courses and events.
Health Equity
Pursuing equity in access to cancer care and outcomes for all Victorians affected by cancer.
Consumer Engagement
Partnering with consumers at every step of our journey, because no-one knows cancer like someone who’s lived it.
About Us
Research, academic and clinical institutions working together to accelerate cancer research, knowledge and expertise to benefit all.
News & Events
The VCCC Alliance brings you the latest in cancer research, education and clinical care through engaging, relevant and informative events.

Analysing the Data

Provides high-level description of statistical analysis and role of the trial Biostatistician.

Extracting datasets from the database

Once the trial data has been cleaned and validated and all data issues resolved, the data should be locked with files protected from editing and deleting. These procedures should be in accordance with the sponsoring institution’s data management standard operating procedures (SOPs) and the trial-specific Data Management Plan.

Following database lock, datasets should be extracted from the trial database for analysis

Undertaking the statistical analysis

The Sponsor-Investigator should ensure that a Biostatistician is included in the clinical trial team. The Biostatistician plays a crucial role throughout the trial, from designing the trial to the analysis and interpretation of the trial data. The statistical analysis should be undertaken, or at least overseen, by the trial Biostatistician. Statistical analysis should be conducted in a statistical package such as Stata or R and it should be reproducible.  

If the trial is contributing to a higher degree, the Biostatistician will be involved in an advisory capacity since students should do their own statistical analysis.  

The analysis should be conducted according to methodology that was outlined and agreed by the trial team before the database was locked. This methodology should be documented in either the protocol or a formal Statistical Analysis Plan (SAP). Sponsor-Investigators should use the SAP template provided by the sponsoring institution, see JAMA Network: Guidelines for the Content of Statistical Analysis Plans in Clinical Trials.

Any deviation from the SAP should be explained in the reporting of the trial results, ie in any manuscript publishing the results and in the Clinical Study Report (applicable only to trials included as part of a regulatory submission).  

Once the statistical analysis is complete, the trial Biostatistician should generate a report for the Sponsor-Investigator which is then used to support any publication of results or write the Clinical Study Report (if applicable). The Biostatistician should be involved in writing publications of the trial data to assist with interpretation of the results.  

Guidelines

Get the latest in cancer news, events and more, direct to your inbox

Join a network of Victorian cancer researchers, clinicians and consumers to keep your finger on the pulse.